25251 Regression Patterns in Non-Melanoma Skin Cancer

Saturday, October 11, 2014: 3:05 PM
Naveed Neil Nosrati, MD , Plastic Surgery, Indiana University, Indianapolis, IN
Jane S Han, BS , Plastic Surgery, Indiana University, Indianapolis, IN
William A. Wooden, MD , Plastic Surgery, IUPUI, School Of Medicine, Indianapolis, IN
Raj Sood, MD , Plastic Surgery, Indiana University, Indianapolis, IN
Imtiaz A Munshi, MD , General Surgery, Indiana University, Indianapolis, IN
Sunil Tholpady, MD, PhD , Plastic Surgery, Indiana University, Indianapolis, IN

The high prevalence of non-melanoma skin cancers (NMSC) creates a significant financial burden for the healthcare system. More cases are diagnosed each year than the next four most common cancers combined. Management of the lesions involves an initial diagnostic biopsy that is often followed by surgical excision. However, the pathologist often finds no evidence of the carcinoma within the excision1-4. This study aims to identify the patient and lesion characteristics associated with regression of these carcinomas, thus allowing for monitoring rather than resource consuming excision.

IRB approval was obtained to construct a database of all NMSCs that were biopsied and subsequently excised in the study period from 2003-2013. Study variables analyzed were patient demographics and co-morbidities, lesion characteristics, histologic findings, and time from biopsy to excision. The dependent logistic outcome variable was whether or not the cancer was present on excision. S+ statistical software was used to analyze the results and provide a numerical estimate of possibility of cancer regression. Cancer regression was defined as a cancer-free pathologic report after excision when a previous biopsy demonstrated a positive margin.

A total of 612 NMSCs with positive biopsy margins in 413 patients were reviewed. There were 342 basal cell carcinomas and 270 squamous cell carcinomas. SCC regressed more than BCC, 54% vs 28%, with an overall rate of 39.5%. Trunk and extremity lesions regressed more than facials lesions. Patients that served in Vietnam had a higher rate of regression at 57%. Agent Orange exposure correlated to increased regression (52%). The pre-excision appearance of a scar demonstrated regression of 59%. The shave biopsies showed 40% regression, while the punch demonstrated 28%. History of skin cancer had no effect.

The presence or absence of NMSC after biopsy is a critical question as resources become more closely guarded. Thus a system by which patient and cancer characteristics can provide some data to the urgency of biopsy excision would be helpful to the plastic surgeon who is often excising these lesions. This current study provides the data that all lesions are not similar and regress differentially. Certain patient characteristics were also found to play a role. Using this data a method may be developed by which to stratify lesions by with a consequent change in management from excision to monitoring.